Hudson Bay Capital Management »

Cellectar Biosciences shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Cellectar Biosciences (CLRB) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Cellectar Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cellectar Biosciences held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cellectar Biosciences by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $597k 150k 3.98

More positions owned by Hudson Bay Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Microsoft Corporation Put Option (MSFT)
NVIDIA Corporation Call Option (NVDA)
Amazon Call Option (AMZN)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl C Put Option (GOOG)
Meta Platforms Cl A Put Option (META)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Put Option (TSLA)
Advanced Micro Devices Put Option (AMD)
Ishares Tr Msci Acwi Etf Put Option (ACWI)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Pioneer Natural Resources Put Option (PXD)
Royal Caribbean Group Note 6.000% 8/1 (Principal)

View all positions for Hudson Bay Capital Management

Top funds holding Cellectar Biosciences

AIGH Capital Management
Nantahala Capital Management
Vanguard Group
ADAR1 Capital Management
Rosalind Advisors
Barclays
Geode Capital Management
Citadel Advisors
Hudson Bay Capital Management
BlackRock
Lighthouse Investment Partners
Jane Street
Northern Trust
Susquehanna International
Goss Wealth Management

View all funds holding Cellectar Biosciences